Home      학술발표회 - 초록 상세보기

  학술발표회 - 초록 상세보기

문의 : 초록(, 참가비(


현재 가능한 작업은 아래와 같습니다.

  • 02월 19일 10시 이후 : 초록수정 불가능, 일정확인 및 검색만 가능
대회명 대한화학회 제121회 학술발표회 및 총회
등록일 2018년 3월 16일 14시 24분 32초
접수번호 6661
발표코드 ORGN1-1 이곳을 클릭하시면 발표코드에 대한 설명을 보실 수 있습니다.
발표시간 목 15시 : 40분
발표형식 분과기념
발표분야 Organic Chemistry - Current Trends in Organic Chemistry I: New Reactions and Methodology
저자 및 공동저자 Sungwoo Hong
Department of Chemistry, Korea Advanced Institute of Science and Technology, Korea
제목 Investigation of Innovative Synthetic Approach for Successful Implementation of Fragment-Based Design
내용 Solutions to problems that are posed by organic, medicinal, biological and material science, demand synthetic innovation with efficient synthetic routes. Our current research is focused on studying breakthrough knowledge in catalytic synthetic methods and molecular design that have high impact on broader scientific fields. The state-of-the-art of approach can be seen using systematic experimental and theoretical methods from three steps: (1) development of innovative synthetic methods that allow rapid access to molecular complexity and structural diversity of privileged fragments, (2) fragment-based drug design (FBDD) and de novo design methods connecting privileged building blocks, (3) development of potent and selective inhibitors based on understanding the mechanisms at the molecular level. The selective C–H bond functionalization has become the favored reaction methods in practical synthetic processes. The new catalytic synthetic methods allow us to perform the unprecedented disconnection of target molecules, affording innovative and imaginative synthetic strategies of so-called “privileged scaffolds”. The power and efficiency of direct C–H functionalization could be further enhanced by combining such catalytic transformations into a one-pot process, which is highly desirable by providing a powerful platform for constructing complicated key motifs from simple starting materials. Subsequent medicinal chemistry studies involving a modular approach and privileged fragments assembly, will provide bases for the development of pharmaceutical agents via structure-based design. The new catalytic synthetic methods will function as competent tools directly utilized in cross coupling reactions capable of connecting privileged building blocks, providing opportunities for the successful implementation of fragment-based drug design (FBDD) and eventually streamline drug discovery research.
- 등록된 그림이 있는경우 그림을 클릭하시면 원본 그림파일을 볼 수 있습니다.
- 최종본을 확인하지 않아 발생된 문제에 대해서는 책임지지 않습니다.
- 미리보기의 그림위치는 임시 위치입니다. 모든 그림파일은 Abstract 하단에 위치하게 됩니다.